EX1 Stock Discussion
Exopharm Limited Description
Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing clinical human therapeutics in Australia. It is developing Plexaris, an exosome derived from human platelets; and Exomeres, an exosome derived from adult stem cells. The company was founded in 2003 and is headquartered in Melbourne, Australia. The Company’s LEAP Technology provides a key step in the downstream manufacturing process to isolate and purify exosomes from adult stem cells.
Industry: Biotechnology
Keywords: Manufacturing Pharmaceutical Biotechnology Biology Biopharmaceutical Manufacturing Process Stem Cell Stem Cells Cell Biology Downstream Adult Stem Cell Exosome Platelet
Recent Comments
- SwingTradeBot on Market Recap for Wednesday, February 28, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
- SwingTradeBot on Market Recap for Thursday, February 22, 2024
From the Blog
Featured Articles